Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer

NCT02338531 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT02338531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02338531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker Research Study for PF-03084014 in cHEmoresistant Triple-negative Breast cAncer
Lead sponsor
Jules Bordet Institute
Phase
Phase 2
Overall status
Withdrawn
Start date
June 30, 2015
Completion date
December 31, 2018
Enrollment
0 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer